299 related articles for article (PubMed ID: 20836623)
1. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
Duceppe N; Tabrizian M
Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based drug nanocarriers: where do we stand?
Garcia-Fuentes M; Alonso MJ
J Control Release; 2012 Jul; 161(2):496-504. PubMed ID: 22480607
[TBL] [Abstract][Full Text] [Related]
3. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
[TBL] [Abstract][Full Text] [Related]
4. Ultrapure chitosan oligomers as carriers for corneal gene transfer.
Klausner EA; Zhang Z; Chapman RL; Multack RF; Volin MV
Biomaterials; 2010 Mar; 31(7):1814-20. PubMed ID: 19879644
[TBL] [Abstract][Full Text] [Related]
5. Chitosan nanoparticles for drug delivery to the eye.
Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
7. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
Wang J; Tao X; Zhang Y; Wei D; Ren Y
Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
[TBL] [Abstract][Full Text] [Related]
8. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based nanoparticles as delivery systems of therapeutic proteins.
Fonte P; Andrade JC; Seabra V; Sarmento B
Methods Mol Biol; 2012; 899():471-87. PubMed ID: 22735970
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent nanoparticles of chitosan complex for real-time monitoring drug release.
Cui W; Lu X; Cui K; Wu J; Wei Y; Lu Q
Langmuir; 2011 Jul; 27(13):8384-90. PubMed ID: 21661743
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability.
Hasanovic A; Zehl M; Reznicek G; Valenta C
J Pharm Pharmacol; 2009 Dec; 61(12):1609-16. PubMed ID: 19958582
[TBL] [Abstract][Full Text] [Related]
17. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
[TBL] [Abstract][Full Text] [Related]
19. Multi-functional nanocarriers for targeted delivery of drugs and genes.
Jabr-Milane L; van Vlerken L; Devalapally H; Shenoy D; Komareddy S; Bhavsar M; Amiji M
J Control Release; 2008 Sep; 130(2):121-8. PubMed ID: 18538887
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]